尊龙凯时·(中国区)人生就是搏!

  • [Product Name]
    Generic Name: Calcium Hydrogen Phosphate Chewable Tablets
  • [Composition]
    Each tablet contains 0.15g Calcium Hydrogen Phosphate. Excipients: Sucrose, Corn Starch, Food Flavoring, Food Coloring, Magnesium Stearate.
  • [Description]
    White, light yellow or light red tablets.
  • [Category]
    Non-prescription mineral supplement.
  • [Actions and Indications]
    For prevention and treatment of calcium deficiency, including osteoporosis, tetany, osteogenesis imperfecta, rickets, and calcium supplementation for children, pregnant and lactating women, menopausal women, and the elderly.
  • [Specification]
    0.15g
  • [Administration and Dosage]
    For oral administration.Chew and swallow. Adults: 3-6 tablets per time, 3 times a day. After meals.
  • [Adverse Reactions]
    Occasional constipation.
  • [Contraindications]
    Contraindicated in patients with hypercalcemia, hypercalciuria, calcium-containing kidney stones or history of kidney stones.
  • [Precautions]
    1. Use with caution in patients with cardiac or renal insufficiency 2. The medicine should not be used by patients with a history of anaphylactic reactions to it, and individuals with allergic tendencies should use it with caution. 3. It should not be used when the properties of this medicine have changed. 4. It should be kept out of reach of children. 5. If you are using other medicine, please consult your physician or pharmacist before using this medicine. [Drug Interactions] 1. Avoid concurrent use with digitalis medications. 2. Large consumption of alcoholic and caffeinated beverages, and heavy smoking may inhibit calcium absorption. 3. High-fiber foods may inhibit calcium absorption due to formation of poorly absorbable compounds. 4. Reduced absorption when used with phenytoin sodium and tetracyclines. 5. Vitamin D, contraceptives, and estrogens may increase calcium absorption. 6. Increased aluminum absorption when taken with aluminum-containing antacids. 7. Risk of hypercalcemia when used with thiazide diuretics (due to increased tubular reabsorption of calcium). 8. Monitor for arrhythmias when used with potassium-containing medications. 9. Consult a healthcare provider or pharmacist about potential drug interactions."
  • [Pharmacological Action]
    Participates in bone formation, bone tissue reconstruction after fractures, muscle contraction, nerve transmission, blood coagulation, and reduces capillary permeability.
  • [Storage]
    Store in tightly sealed container.
  • [Package]
    High-density polyethylene bottle for oral solid medications, 90 tablets per bottle.
  • [Shelf Life]
    Provisional 24 months
  • [Drug Standards]
    National National Drug Standard for Chemical Drugs, Volume XV, WS-10001-(HD-1394)-2003
  • [Approval Code]
    GYZZ H41025252
  • [Revision Date]
    December 01, 2015
  • [Marketing Authorization Holder]
    Taikang Haien Pharmaceutical Co., Ltd. Address: Taikang Industrial Cluster Area
  • [Manufacturer]
    Taikang Haien Pharmaceutical Co., Ltd.